# Ceftazidime

NDC: 25021-128
Generic name: ceftazidime
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20080515

FDA application: ANDA062640

## Active ingredients

- CEFTAZIDIME: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-128"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-128
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=112c5457-8d71-49f5-b531-9761d7d38c93